From: Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotics | Count | Percent |
---|---|---|
Risperidone (oral) + Quetiapine | 355 | 6.2 |
Risperidone (oral) + Haloperidol | 272 | 4.8 |
Haloperidol + Levomepromazine | 266 | 4.7 |
Risperidone (oral) + Olanzapine | 237 | 4.2 |
Risperidone (oral) + Levomepromazine | 232 | 4.1 |
Olanzapine + Haloperidol | 226 | 4.0 |
Olanzapine + Quetiapine | 216 | 3.8 |
Haloperidol + Quetiapine | 204 | 3.6 |
Olanzapine + Levomepromazine | 189 | 3.3 |
Olanzapine + Clothiapine | 176 | 3.1 |
Risperidone (oral) + Risperidone LAI | 162 | 2.9 |
Olanzapine + Amisulpride | 131 | 2.3 |
Olanzapine + Risperidone LAI | 123 | 2.2 |
Levomepromazine + Quetiapine | 118 | 2.1 |
Risperidone (oral) + Clothiapine | 115 | 2.0 |